EyePoint Pharmaceuticals's total assets for Q2 2025 were $301.15M, a decrease of -16.94% from the previous quarter. EYPT total liabilities were $55.14M for the fiscal quarter, a -14.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.